Phoenix New Media Hong Kong stocks | Today, the Hang Seng Index rose in early trading and continued to fall in the afternoon. By the close, the Hang Seng Index was down 0.43% at 24112 points, the State-owned Enterprises Index was down 0.18% at 8449 points, and the Hang Seng Technology Index was down 0.45% at 5698 points.
Among blue chips, Country Garden Holdings (02007) rose 4.94%, Haidilao International Holding (06862) rose 3.37%, ANTA Sports Products (02020) rose 2.31%, CSPC Pharmaceutical (01093) fell 3.23%, Sands China (01928) fell 2.86%, and Tencent (00700) fell 2.75%.
Inner housing stocks strengthened, Country Garden Holdings (02007) rose 4.94%, China Vanke (02202) rose 4.42%, Shimao Group (00813) rose 4.14%, R & F Real Estate (02777) rose 3.61%, Metro Development Holdings (01030) rose more than 2%, and Agile Group (03383) rose 0.57%. According to the National Bureau of Statistics, real estate GDP in the fourth quarter of 2021 fell 2.9 per cent year-on-year and grew 5.2 per cent year-on-year.
The biomedical sector strengthened in early trading and fell back in the afternoon. Peijia Medical (09996) 13.24%, Golly Pharmaceutical (01672) rose 4.30%, Development Pharmaceutical (09939) rose 1.03%, and Tengsheng Boyao (02137) rose 0.22%. On the news side, according to Alibaba Health Information Technology, Nuohui health product claustrophobia will be put on the market on January 18, 2022. The YouTube is the first consumer self-test product of Helicobacter pylori approved by the State Drug Administration, which realizes the integrated design of sampling and testing.
The concept of electric power rose strongly, Huaneng International Power (00902) rose 5.23%, China Electric Power (02380) rose 5.10%, China Resources Power Holdings (00836) rose 4.94%, Huadian International Power (01071) rose 2.40%, and Datang Power Generation (00991) rose 1.94%. According to the electricity consumption data of the whole society released by the National Energy Administration in 2021, the electricity consumption of the whole society will be 8.3128 trillion kilowatt hours in 2021, an annual increase of 10.3 percent, an increase of 14.7 percent over the same period in 2019, and an average increase of 7.1 percent in two years. In terms of sub-industries, the electricity consumption of the primary industry was 102.3 billion kilowatt-hours, an annual increase of 16.4 percent; that of the secondary industry was 5.6131 trillion kilowatt-hours, an annual increase of 9.1 percent; that of the tertiary industry was 1.4231 trillion kilowatt-hours, an annual increase of 17.8 percent; and that of urban and rural residents was 1.1743 trillion kilowatt-hours, an annual increase of 7.3 percent.
Catering stocks rebounded, with 99 Mao (09922) up 7.07%, Haidilao International Holding (06862) up 3.37%, Nai Xue's tea (02150) up 2.57%, and Jiabu (00520) up 0.81%.
Man Wah (01999) rose 7.18% to 12.54 yuan. The company announced that it will repurchase 2 million shares on January 14, 2022 at a repurchase price of HK $11.76 to HK $12.02 per share, involving a capital of HK $23.9878 million. In addition, Guojin Securities pointed out that the bank as a whole judged that the revenue end of most head home enterprises still achieved relatively ideal growth in the fourth quarter of 2021, and the profit side of software home enterprises will also meet previous expectations. Guojin also stressed that it has been basically proved at the end of the real estate policy that the overall household demand is expected to usher in a marginal reversal, and the sustainability of the overall market of the plate is worth looking forward to.
Peijia Medical-B (09996) was at 13.00 yuan, up 13.24%. The company announced that the group has recently worked with the American medical device company Jena ValveTechnology,Inc. (licensor) enters into cooperation and licensing agreements, service agreements and share purchase agreements (collectively referred to as "these agreements"). Under these agreements, Jena Valve has granted exclusive licenses to the Group for certain proprietary transcatheter aortic valve replacement ("TAVR") products ("related products") for the treatment of aortic regurgitation and aortic valve stenosis. The Group has the right to develop, manufacture and commercialize relevant products in Greater China, and Licensor agrees to provide services to assist the Group in developing the value of the relevant products in the region. The Group has also acquired a number of preferred shares in Jena Valve, which is equivalent to a small equity investment in Licensor. At present, almost all TAVR products approved by China are only suitable for the treatment of aortic valve stenosis, not aortic regurgitation. There is no approved transfemoral TAVR product for the treatment of aortic regurgitation in China. The Trilogy heart valve system developed by Jena Valve is the first and only transfemoral device approved by the CE mark for the treatment of severe symptomatic aortic regurgitation and aortic stenosis. The system has also received groundbreaking device certification from the US Food and Drug Administration.
Pop Mart International (09992) rose 5.01% to 48.20 yuan. UBS released a research report saying it gave Pop Mart International a "buy" rating for the first time, with a target price of HK $61.50. It is expected that the sales of Bubble Matt's new IP (intellectual property) and the expansion of existing IP's new product lines and categories may stimulate stock price performance. Pop Mart International is the leader in the mainland's popular toy industry, with a high market share in 2020, the bank said. Although investors are more worried about the sustainability of the business, sending its share price down 60 per cent from its peak in the first half of last year, the bank believes demand for popular toys is robust. In an environment such as the resurgence of the epidemic, it is believed that the Group's business is more defensive than other non-essential consumption such as restaurants, clothing and footwear.
Nuohui Health (06606) rose more than 22% in morning trading, then fell throughout the day to close at 28.0 yuan, down 0.36%. According to the announcement, the group's total revenue in 2021 is expected to be 205 million-217 million yuan, an increase of 190.8% to 207.8% over the same period last year, while gross profit is about 147 million-158 million yuan, an increase of 294.6% to 324.2% over the same period last year. The increase in total revenue and gross profit is mainly due to the increase in revenue and gross profit of the company's products (that is, Chang Weiqing and Pupu tube), resulting in a substantial increase in total revenue. In addition, according to Nuohui Health announcement, the YouTube is the first consumer self-test product of Helicobacter pylori approved by the State Drug Administration, realizing the integrated design of sampling and testing. According to Alibaba Health Information Technology, the claustrophobia will go on sale on January 18, 2022.